Table II.
Study subject | Genotype
|
P-value
|
Hardy-Weinberg P-value | |||
---|---|---|---|---|---|---|
CC | CT | TT | Dominant | Recessive | ||
Serum concentrations of triglycerides | ||||||
Subject panel A | 1.55±1.06 | 1.65±1.03 | 2.34±3.72 | 0.0101 | 0.0004 | |
No. of subjects | 2,649 | 505 | 26 | 0.7210 | ||
Subject panel B | 1.65±1.03 | 1.82±1.57 | 1.69±0.75 | 0.0010 | 0.9229 | |
No. of subjects | 3,629 | 603 | 31 | 0.2806 | ||
Korean population | 1.47±0.98 | 1.53±0.88 | 1.94±2.07 | 0.0579 | 0.0095 | |
No. of subjects | 2,568 | 670 | 32 | 0.1068 | ||
All study subjects | 1.57±0.01 | 1.66±1.20 | 1.97±2.39 | 7.8×10−5 | 0.0008 | |
No. of subjects | 8,846 | 1,778 | 89 | 0.9737 | ||
Serum concentrations of HDL-cholesterol | ||||||
Subject panel A | 1.35±0.41 | 1.30±0.38 | 1.27±0.36 | 0.0047 | 0.3644 | |
No. of subjects | 2,675 | 510 | 24 | 0.9544 | ||
Subject panel B | 1.41±0.39 | 1.35±0.41 | 1.34±0.40 | 0.0015 | 0.4458 | |
No. of subjects | 3,611 | 597 | 30 | 0.3297 | ||
Korean population | 1.25±0.36 | 1.27±0.40 | 1.20±0.33 | 0.3611 | 0.4020 | |
No. of subjects | 2,577 | 674 | 32 | 0.0974 | ||
All study subjects | 1.35±0.39 | 1.31±0.40 | 1.27±0.37 | 4.3×10−5 | 0.1058 | |
No. of subjects | 8,863 | 1,781 | 86 | 0.7379 | ||
Serum concentrations of LDL-cholesterol | ||||||
Subject panel A | 3.10±0.86 | 3.16±0.97 | 3.15±0.91 | 0.1878 | 0.8209 | |
No. of subjects | 2,580 | 486 | 23 | 0.9828 | ||
Subject panel B | 3.01±0.86 | 3.02±0.91 | 3.44±1.11 | 0.3909 | 0.0059 | |
No. of subjects | 3,604 | 591 | 31 | 0.2128 | ||
Korean population | 2.85±0.91 | 2.85±0.92 | 2.97±1.05 | 0.9288 | 0.4451 | |
No. of subjects | 2,514 | 656 | 31 | 0.1001 | ||
All study subjects | 2.99±0.88 | 2.99±0.94 | 3.19±1.04 | 0.5875 | 0.0372 | |
No. of subjects | 8,698 | 1,733 | 85 | 0.8970 |
P-values of <0.05 are shown in bold.